1. Home
  2. RLMD vs HOLO Comparison

RLMD vs HOLO Comparison

Compare RLMD & HOLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • HOLO
  • Stock Information
  • Founded
  • RLMD 2004
  • HOLO 2018
  • Country
  • RLMD United States
  • HOLO China
  • Employees
  • RLMD N/A
  • HOLO N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • HOLO Computer Software: Programming Data Processing
  • Sector
  • RLMD Health Care
  • HOLO Technology
  • Exchange
  • RLMD Nasdaq
  • HOLO Nasdaq
  • Market Cap
  • RLMD 22.0M
  • HOLO 24.9M
  • IPO Year
  • RLMD N/A
  • HOLO N/A
  • Fundamental
  • Price
  • RLMD $0.61
  • HOLO $7.09
  • Analyst Decision
  • RLMD Buy
  • HOLO
  • Analyst Count
  • RLMD 3
  • HOLO 0
  • Target Price
  • RLMD $5.00
  • HOLO N/A
  • AVG Volume (30 Days)
  • RLMD 338.9K
  • HOLO 4.2M
  • Earning Date
  • RLMD 08-06-2025
  • HOLO 01-01-0001
  • Dividend Yield
  • RLMD N/A
  • HOLO N/A
  • EPS Growth
  • RLMD N/A
  • HOLO N/A
  • EPS
  • RLMD N/A
  • HOLO N/A
  • Revenue
  • RLMD N/A
  • HOLO $39,771,750.00
  • Revenue This Year
  • RLMD N/A
  • HOLO N/A
  • Revenue Next Year
  • RLMD N/A
  • HOLO N/A
  • P/E Ratio
  • RLMD N/A
  • HOLO N/A
  • Revenue Growth
  • RLMD N/A
  • HOLO 42.62
  • 52 Week Low
  • RLMD $0.24
  • HOLO $4.16
  • 52 Week High
  • RLMD $4.47
  • HOLO $608.00
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 47.74
  • HOLO 53.39
  • Support Level
  • RLMD $0.60
  • HOLO $4.84
  • Resistance Level
  • RLMD $0.69
  • HOLO $6.20
  • Average True Range (ATR)
  • RLMD 0.07
  • HOLO 0.46
  • MACD
  • RLMD -0.01
  • HOLO 0.37
  • Stochastic Oscillator
  • RLMD 41.86
  • HOLO 91.11

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About HOLO MicroCloud Hologram Inc.

MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library. Geographically company is operating in single segment, China.

Share on Social Networks: